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Abstract
Background: Early trauma-focused cognitive-behavioural therapy (TFCBT) holds promise as a preventive
intervention for people at risk of developing chronic post-traumatic stress disorder (PTSD). The aim of
this review was to provide an updated evaluation of the effectiveness of early TFCBT on the prevention
of PTSD in high risk populations.
Methods: We performed a systematic literature search in international electronic databases (MEDLINE,
EMBASE, PsycINFO, CENTRAL, CINAHL, ISI and PILOTS) and included randomised controlled trials
comparing TFCBT delivered within 3 months of trauma, to alternative interventions. All included studies
were critically appraised using a standardised checklist. Two independent reviewers selected studies for
inclusion and assessed study quality. Data extraction was performed by one reviewer and controlled by
another. Where appropriate, we entered study results into meta-analyses.
Results: Seven articles reporting the results of five RCTs were included. All compared TFCBT to
supportive counselling (SC). The study population was patients with acute stress disorder (ASD) in four
trials, and with a PTSD diagnosis disregarding the duration criterion in the fifth trial. The overall relative
risk (RR) for a PTSD diagnosis was 0.56 (95% CI 0.42 to 0.76), 1.09 (95% CI 0.46 to 2.61) and 0.73 (95%
CI 0.51 to 1.04) at 3–6 months, 9 months and 3–4 years post treatment, respectively. A subgroup analysis
of the four ASD studies only resulted in RR = 0.36 (95% CI 0.17 to 0.78) for PTSD at 3–6 months. Anxiety
and depression scores were generally lower in the TFCBT groups than in the SC groups.
Conclusion: There is evidence for the effectiveness of TFCBT compared to SC in preventing chronic
PTSD in patients with an initial ASD diagnosis. As this evidence originates from one research team
replications are necessary to assess generalisability. The evidence about the effectiveness of TFCBT in
traumatised populations without an ASD diagnosis is insufficient.
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People exposed to stressful events may develop trauma-
related psychiatric conditions. Clinicians, researchers and
policymakers are increasingly interested in early interven-
tions to prevent the development of chronic mental
health problems such as post-traumatic stress disorder
(PTSD) [1]. Psychological debriefing (PD) has perhaps
been the most widespread among such early interven-
tions. However, systematic reviews have failed to show
any effectiveness of one-session PD when given to all
exposed individuals [2-5]. Trauma-focused cognitive
behaviour therapy (TFCBT) is the recommended early
intervention for people with acute stress disorder (ASD)
or acute PTSD in National Institute for Health and Clini-
cal Excellence's guidelines [1]. The recommendation is
based on a systematic review that included nine studies
retrieved from a literature search in January 2004. There
was limited and inconclusive evidence that TFCBT deliv-
ered between 1 and 6 months after trauma was more effec-
tive than being on a waiting list, or receiving alternative
psychosocial interventions. Our objective was to provide
an updated evaluation of the effectiveness of early TFCBT
compared to other psychosocial interventions in prevent-
ing PTSD, anxiety and depression among adults with ASD
or PTSD symptoms.
Methods
This systematic review is based on two health technology
assessments (HTAs) of early psychosocial interventions
following traumatic events [6,7]. The HTAs were commis-
sioned by the Norwegian Directorate for Health and
Social Affairs to obtain an overview of all kinds of early
psychosocial interventions following all types of trau-
matic events, and to use the evidence in the development
of clinical guidelines. As the objective of this review is nar-
rower than that of the HTAs, we have performed a new lit-
erature search and applied a refined set of study eligibility
criteria.
We searched MEDLINE, Embase, PsycINFO, CINAHL,
Cochrane Central Register of Controlled Trials (CEN-
TRAL), ISI Web of Science and PILOTS, with each database
being searched from inception to June or July 2007. We
used subject headings and text words for PTSD symptoms
and cognitive-behavioural therapy combined with Ovid's
optimised search strategy for randomised trials developed
and validated by the Health Information Research Unit at
McMaster University [8]. The search was restricted to adult
populations.
Study selection
We included studies that met the following criteria:
- randomised controlled trial (RCT) published in peer-
reviewed scientific journal
- a study population of adults with symptoms of acute
stress disorder (ASD) or symptoms of post-traumatic
stress disorder (PTSD)
- individual TFCBT initiated within three months post
trauma
- a non-pharmacological comparison intervention
- outcomes measured as symptoms and/or diagnosis of
PTSD (primary outcome), anxiety and/or depression (sec-
ondary outcomes) at follow up (minimum one month
after treatment completion).
Individual TFCBT was defined as an intervention with at
least four planned sessions, regardless of the number of
sessions actually completed. At least one of the following
techniques should be included in the intervention: expo-
sure, systematic desensitization, stress inoculation train-
ing, cognitive processing therapy, cognitive therapy,
assertiveness training, biofeedback, relaxation training.
The minimum of four sessions was chosen to differentiate
TFCBT from debriefing techniques, which may resemble
TFCBT in some respects, but are given over one or two ses-
sions only. We did not include studies that compared the
effectiveness of TFCBT to conditions with no interven-
tions, such as waiting list controls. There is, at least in Nor-
way, a public expectation to offer some kind of mental
health care to traumatised people, and many would per-
ceive no intervention or delayed interventions as unethi-
cal. Therefore, our objective was to evaluate whether or
not TFCBT was more effective than other interventions.
We excluded studies in other languages than English, the
Scandinavian languages, French and Italian. Independent
pairs of reviewers selected studies for inclusion. A third
reviewer was consulted to resolve any disagreement
regarding inclusion decisions.
Quality assessment
We assessed the methodological quality of included stud-
ies on the basis of randomisation, adequate concealment
of randomisation, level of blinding, use of intention-to-
treat (ITT) analysis and description of loss to follow up.
Two reviewers assessed study quality independently using
a checklist developed at the Norwegian Knowledge Centre
for the Health Services, based on "User's Guides to the
Medical Literature" [9].
Data extraction
One reviewer extracted data from the studies into pre-
designed data forms including study, patient and inter-
vention characteristics, relevant outcome measures and
study results. At least one other reviewer checked extracted
data and any disagreement were resolved by discussion.Page 2 of 8
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as a single study.
Data synthesis
We used the Review Manager 4.2 software (Nordic
Cochrane Centre, 2003) for meta-analysis where patients,
interventions and outcomes were consistent enough
across studies to justify pooling. Effect estimates were risk
ratio (RR) and standardised mean difference (SMD) with
95% confidence intervals (CI) for dichotomous and con-
tinuous outcomes, respectively. We used SMD even when
studies used the same assessment instrument for an out-
come to accommodate the evaluations of clinical mean-
ingfulness (see below). We used a fixed-effects model to
calculate effect estimates when the I2-test for heterogene-
ity was less than 30%. Otherwise we used the random-
effects model. We adhered to Bisson and coworkers'
threshold criteria for clinically meaningful effect estimates
when two active treatments are compared: SMD ≤ -0.5 or
≥ 0.5, and RR ≤ 0.80 or ≥ 1.25 [10]. Further, 95% confi-
dence intervals for clinically meaningful effect estimates
should not cross the thresholds.
Results
The searches identified 1438 studies, of which 857
remained after removal of duplicates (Figure 1). Fifty
seven references appeared to meet our eligibility criteria
and were obtained in full text. We included seven of these
articles.
Study characteristics
The seven articles originated from five different RCTs: in
addition to one article for each trial, long-term follow-up
outcomes for three of the RCTs [11-13] were reported in
two articles [14,15] (Tables 1 and 2). The total number of
randomised participants across studies was 257. There
was a female majority (ranging from 50% to 100%)
among the participants in all the trials and the average age
ranged from 29 to 37 years. Participants had been exposed
to motor vehicle or industrial accidents or assaults 2 – 46
days prior to study inclusion. Mean pre-treatment scores
on the Impact of Event Scale (IES) indicated clinically sig-
nificant levels of posttraumatic symptoms (IES Total > 19,
Intrusion and Avoidance subscales > 9) [16].
All included studies compared TFCBT with supportive
counselling (SC). The SC programs consisted of active lis-
tening and education about trauma and general problem-
solving skills. Cognitive restructuring, exposure tech-
niques and other forms of focusing on the individual's
specific traumatic experience were avoided.
Two studies had an additional intervention arm: TFCBT +
anxiety management [12] and TFCBT + hypnosis [13,15],
respectively. In our view, anxiety management and hyp-
nosis can be considered components of TFCBT. The addi-
tional intervention arms were therefore treated as TFCBT
groups. We merged the pure TFCBT groups and TFCBT +
anxiety management/hypnosis groups when we calcu-
lated the pooled relative risk for PTSD diagnosis (the only
dichotomous outcome). In the analyses of continuous
outcomes we pooled the means and standard deviations
in the pure TFCBT arms and the TFCBT + additional com-
ponent arms. Pooled means were calculated with the fol-
lowing formula: (mean1 *n1) + (mean2 *n2)/n1 + n2 where
n is number of participants, 1 is arm 1 and 2 is arm 2.
Pooled standard deviations were calculated with the fol-
lowing formula:
where s is standard deviation, p is pooled, n is number of
participants, 1 is arm 1, 2 is arm 2, k is arm k and k is
number of arms.
One study used assessment only as a third study arm [17].
The assessment only condition was not entered into our
meta-analysis, as we only included comparisons that were
active treatments.
Methodological quality
All the included RCTs had in common that the randomi-
sation procedures were insufficiently described and that
concealment of allocation was not addressed. Additional
shortcomings of three of the RCTs [12,13,15,17] were a
lack of intention to treat analysis and that dropouts were
not accounted for.
Clinical effectiveness
All five RCTs reported PTSD diagnosis at 3–6 months post
treatment. Thirty two percent (47 of 145 participants) in
the TFCBT groups had a PTSD diagnosis versus 58% (51/
88) in the SC groups (Figure 2). The effect estimate was
statistically significant, but the study results were hetero-
geneous. We performed post hoc subgroup analyses to
explore the heterogeneity. An analysis excluding Foa and
coworkers' study [17] did not remove heterogeneity (I2 =
61%), but when we also excluded Bryant and coworkers'
2005 study [13] homogeneity was achieved (I2 = 0%).
Combining the Foa and the Bryant 2005 studies only
resulted in I2 = 35%.
The PTSD rates were 32% (7/22) in the TFCBT group ver-
sus 29% (7/24) in SC group at 9 months [17], and 37%
(42/113) versus 48% (26/54) after 3–4 years [14,15]. The
9-month and 3–4-year effect estimates were not statisti-
cally significant.
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on IES subscales Intrusion and Avoidance at 6 months fol-
low-up. The TFCBT groups' mean Intrusion and Avoid-
ance scores were significantly lower than those of the SC
groups. The SMDs were statistically significant, but there
was mild heterogeneity between Avoidance estimates.
Foa and coworkers [17] reported interviewer-rated and
self-rated PTSD severity at 3 and 9 months post-treatment.
Group differences varied in directions and were not statis-
tically significant. All included studies reported symptom
levels for anxiety and depression at 3–6 months follow-
up: there was tendency towards lower symptom levels for
TFCBT than for SC. The tendency was confirmed for
depression symptoms by one study at 3 years follow-up
[14].
Clinical meaningfulness
None of the effect estimates met the criteria we had
selected for clinical meaningfulness (Table 3). There was
limited evidence for the superior effectiveness of TFCBT
compared to SC on PTSD when assessed 3–6 and 36–48
months post treatment, on IES subscales Intrusion and
Avoidance and on anxiety when assessed 3–6 months
post treatment and depression assessed 36 months post
treatment. There was inconclusive evidence for the superi-
ority of TFCBT compared to SC on self-rated PTSD sever-
ity, on anxiety 9 months post treatment and depression
3–6 and 9 months post treatment. The evidence was also
inconclusive for the superiority of SC compared to TFCBT
on PTSD diagnosis and interviewer-rated PTSD severity 9
months post treatment.
However, clinical meaningfulness was achieved for PTSD
at 3–6 months in a post hoc subgroup analysis of the four
Bryant studies only (RR 0.36; 95% CI 0.17 – 0.78).
Flow chart of study inclusion processigure 1
Flow chart of study inclusion process.
MEDLINE 215 
EMBASE 315 
PsycINFO 358 
CENTRAL 183 
CINAHL 69 
ISI 129 
PILOTS 169 
Total 1438 
 
857 abstracts screened 
57 articles obtained in 
full text 
581 duplicates
800 irrelevant reports
50 excluded: 
> 3 months since trauma 39 
< 4 sessions 5 
Not RCT 2 
No CBT 2 
No comparison intervention 1 
Irrelevant outcome 1 7 articles met 
inclusion criteria Page 4 of 8
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We identified and included seven articles reporting results
from five randomised controlled trials comparing the
effects of TFCBT with supportive counselling (SC). The
evidence was not conclusive, but there was a tendency
towards TFCBT being more effective than SC in preventing
PTSD, and reducing PTSD, anxiety and depression symp-
toms. The tendency for TFCBT to be more effective than
SC supports the findings in the systematic review that the
National Institute for Health and Clinical Excellence's
guidelines are based on [1].
Four of the included studies [11-15,18] had been carried
out with very similar research protocols in Australia by
Richard Bryant and his research team, while Edna Foa and
her team in the USA were responsible for the fifth study
[17]. The Australian and the US populations differed in
several ways. The Australian population was mixed with
regard to sex and type of trauma exposure, and time since
trauma was less than 14 days at first assessment. The US
population was female assault victims assessed 2–46 days
after trauma. More importantly, a DSM-IV acute stress dis-
order (ASD) diagnosis was an inclusion criterion in the
Australian studies, while a DSM-IV PTSD diagnosis disre-
garding the duration criterion was sufficient in the US
study. As the ASD diagnosis requires the presence of at
least three dissociative symptoms [19], the Australian
study participants were more severely affected by the trau-
matic events, and it seems appropriate to assume that this
important difference in study populations influenced
treatment effectiveness on chronic PTSD.
The meta-analysis of PTSD at 3–6 months showed a het-
erogeneity that might reflect the population differences:
there was a lower PTSD prevalence in the Australian
TFCBT groups than in the SC groups, while there was no
difference between the US groups. When we removed the
Foa study from the meta-analysis we obtained a clinically
meaningful effect estimate and evidence for TFCBT's supe-
riority over SC in preventing chronic PTSD.
However, it was somewhat surprising that results still were
heterogeneous in the subgroup analysis of the Bryant
studies only. It seems like the largest and most recent Bry-
ant study [13] accounted for the heterogeneity, as homo-
geneity was achieved on removal of that study from the
subgroup analysis. The authors of the original paper point
out the high attrition rate in the TFCBT groups as a possi-
ble explanation for the lack of a treatment effect in the
Table 1: Characteristics of included studies
First author, 
publication year 
and country
Participants 
randomised/in post-
treatment analyses, n
Age, years 
(s.d.)
Female % Traumatic events 
and primary 
diagnosis
Time since 
trauma, days (s.d.)
TFCBT technique(s) and 
comparison intervention
Bryant 1998 
Australia [11]
24/24 32 (12.6)
33 (11.4)
58 MVA Industrial 
accident ASD
10 (4.2)
10 (5.0)
7 (2.5)
Education, relaxation training, 
imaginal exposure, cognitive 
restructuring, in vivo exposure
Supportive counselling
Bryant 1999 
Australia [12]
56/41 33 (10.9)
33 (13.4)
37 (12.0)
50 MVA Nonsexual 
assault ASD
10 (3.3)
10 (4.1)
11 (3.4)
Education, imaginal exposure, 
cognitive restructuring, in vivo 
exposure
TFCBT + anxiety management 
Supportive counselling
Bryant 2003a 
Australia [18]
24/24 29 (13.9)
33 (14.4)
67 MVA Nonsexual 
assault ASD
< 14 Education, relaxation training, 
imaginal exposure, cognitive 
restructuring, in vivo exposure
Supportive counselling
Bryant 2003b 
Australia [14]
80/41 Follow-up of participants in 
Bryant 1998 and Bryant 1999
Bryant 2005, 
Bryant 2006 
Australia [13,15]
87/69/53 33 (12.5)
33 (7.7)
35 (13.3)
61 MVA Nonsexual 
assault ASD
16 (8.8)
14 (6.7)
14 (8.4)
Imaginal exposure, cognitive 
restructuring, in vivo exposure
TFCBT + hypnosis
Supportive counselling
Foa 2006 USA 
[17]
90/57/66 34 (11.1) 100 Sexual/nonsexual 
assault PTSD 
(not duration 
criterion)
21 (range: 2–46) Education, relaxation training, 
imaginal exposure, cognitive 
restructuring, in vivo exposure
Supportive counselling 
Assessments only
ASD, acute stress disorder (DSM-IV); PTSD, posttraumatic stress disorder (DSM-IV, not duration criterion); MVA, motor vehicle accident; TFCBT, 
trauma-focused cognitive-behavioural therapy; CIDI, Composite International Diagnostic Interview; IES, Impact of Event Scale; BDI, Beck's 
Depression Inventory; STAI, State/Trait Anxiety Inventory; CAPS-2, Clinician Administered PTSD Scale; BAI, Beck's Anxiety Inventory; PSS-I/-SR, 
PTSD Symptom Scale-Interview/-Self-Report; ITT, intention to treat; LOCF, last observation carried forward.Page 5 of 8
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Table 2: Characteristics of included studies (continued)
First author, publication year 
and country
Treatment duration and 
provider competence
Outcome measures Post-treatment 
follow-up
ITT analysis
Bryant 1998 Australia [11] 5 × 90 minutes Clinical 
psychologists
CIDI (PTSD diagnosis)
IES (intrusion/avoidance)
BDI (depression)
STAI (state/trait anxiety)
6 months (post 
trauma)
Yes
Bryant 1999 Australia [12] 5 × 90 minutes Clinical 
psychologists
CAPS-2 (PTSD diagnosis)
IES (intrusion/avoidance)
BDI (depression)
STAI (state/trait anxiety)
6 months No (completers only)
Bryant 2003a Australia [18] 5 × 90 minutes Clinical 
psychologists
CAPS-2 (PTSD diagnosis)
IES (intrusion/avoidance)
BAI (anxiety)
BDI (depression)
6 months Yes
Bryant 2003b Australia [14] CAPS (PTSD diagnosis) 4 years Yes (LOCF)
Bryant 2005, Bryant 2006 
Australia [13,15]
5 × 90 minutes Clinical 
psychologists
CAPS-2 
(PTSD diagnosis/symptoms)
IES (intrusion/avoidance)
BAI (anxiety)
BDI (depression)
6 months 3 years Yes (LOCF)
Foa 2006 USA [17] 4 × 120 minutes Master's 
and doctoral level therapists
PSS-I/PSS-SR 
(PTSD diagnosis/severity)
BAI (anxiety)
BDI (depression)
2, 3, 6, 9 and 12 
months
Completers only
ASD, acute stress disorder (DSM-IV); PTSD, posttraumatic stress disorder (DSM-IV, not duration criterion); MVA, motor vehicle accident; TFCBT, 
trauma-focused cognitive-behavioural therapy; CIDI, Composite International Diagnostic Interview; IES, Impact of Event Scale; BDI, Beck's 
Depression Inventory; STAI, State/Trait Anxiety Inventory; CAPS-2, Clinician Administered PTSD Scale; BAI, Beck's Anxiety Inventory; PSS-I/-SR, 
PTSD Symptom Scale-Interview/-Self-Report; ITT, intention to treat; LOCF, last observation carried forward.
Meta-analysis of PTSD diagnosis at 3–6 months, 9 months and 3–4 yearsFigure 2
Meta-analysis of PTSD diagnosis at 3–6 months, 9 months and 3–4 years.
BMC Psychiatry 2008, 8:81 http://www.biomedcentral.com/1471-244X/8/81Bryant 2005 study. Apparently, attrition was more evenly
distributed in the other Bryant studies.
Conclusion
TFCBT had limited effectiveness in preventing chronic
PTSD in a clinically heterogeneous population. However,
the evidence for the effectiveness of TFCBT in individuals
with ASD seems clinically meaningful enough to have
implications for practice. It supports an approach where
mental health care facilities screen recently traumatised
patients for ASD and consider offering TFCBT to those
with a diagnosis. Replications are necessary to evaluate
the effectiveness of TFCBT outside Australia, where all
existing trials with ASD patients have been conducted.
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